Diabetic Ulcer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Diabetic Ulcer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Diabetic Ulcer Treatment Market

The diabetic ulcer treatment market size was valued at USD 8.32 billion in 2020, and the market is now projected to grow to USD 18.41 billion in 2028 exhibiting a CAGR of 6.4% during the forecast period of 2024-2032.

The COVID-19 impact led to a negative shift in the diabetic ulcer treatment market since the pandemic broke out; the patients’ attendance and treatments were reduced, and the resources were shifted to combat the virus. They prevented fragile patients from reaching specialized facilities, ulcers worsening or developing complications. Wound care products were also affected by supply chain disruptions and affected treatment. Nevertheless, we have seen that the crisis has hastened the development of telemedicine and distant patient monitoring, stimulating innovation in the management of diabetic wounds. Based on the pandemic shift in focus, the market is likely to increase after the pandemic as healthcare systems shift back to chronic diseases.

The diabetic ulcer treatment market is developing with new technologies and improved approach to the patient’s needs. It has observed that key factors within the product include bioengineered skin substitutes, and enhanced wound dressings that help to enhance the rate of healing. Stem cell therapy is a type of regenerative medicine that is gradually being admitted due to affording treatment to the affected tissue. Telemedicine and remote monitoring tools help effective wound management as well as increase patient cooperation. Also, tailored and individualized management employing AI is enhancing results. These trends inform improved and efficient strategies towards the management of diabetic ulcers. Thus, all the above mentioned factors are contributing towards diabetic ulcer treatment market growth.

Diabetic ulcer treatment market is moving forward by the increasing rate of diagnosed diabetes along with complications such as foot ulcers. An ageing global population also increases the demand to extent this growing industry as elderly persons are prone to chronic wounds. The factors include raising consciousness of the citizens on the prospects of early intervention and the availability of improved technologies including the bioengineered skin substitution products and growth factors. Audience Industry comprises of several elements, which include: Government campaigns and health care management in diabetes also contributes to the strategy. Also, the use of telemedicine and AI applications improves patient outcomes, and contributes to the market growth.

Comprehensive Analysis Diabetic Ulcer Treatment Market

The diabetic ulcer treatment market based on Geography can be segmented by Ulcer Type, Treatment Type and End Users. Depending to the ulcer type it can be a foot ulcer, neuropathic ulcer, ischemic ulcer, neuro-ischemic ulcer, mouth ulcer and others. By the treatment type it majorly includes wound care dressings such as antimicrobial, foam, film, alginate, hydrogel & others; and wound care devices like NPWT, ultrasound therapy, and HBOT. Other surgical and bioactive treatments are also well represented and include grafts, substitutes including growth factors. The various customer segments from the market’s perspective include; the hospitals, clinic, ambulatory surgical centers and home care where patients have diverse needs.

North America is the largest market for diabetic ulcer treatment due to better facilities for treatment, and better knowledge of the diabetic population for ulcer management. The area enjoys substantial spending on research and development for these new therapies, for instance, bioengineered skin substitutes and specialized wound care instruments. Market growth is further backed by proper reimbursement policies as well as government support. Additional to that, increase in cases of telemedicine, NPWT and HBOT and other advanced treatments are some of the other factors that have led to the growth of the market.

Key players in this sector include Coloplast Corp (Denmark), Smith & Nephew (UK), ConvaTec Group Plc (UK), Mölnlycke Health Care AB (Sweden), 3M (U.S.), Integra LifeSciences Corporation (U.S.), Cardinal Health (U.S.), Tissue Regenix (UK).

As illustrated for the year 2024, technological advancements in the diabetic ulcer treatment market cater towards novel official products for wounds. For instance, hydro-gels and nano-particles have been integrated into treatment to advance cure by promoting the release of bioactive molecules, as well as the antimicrobial agents. This method enables rapid healing and better outcome of the affected tissues. However, basic nanofiber scaffolds containing peptides are also developing for effective healing due to fibroblast cell growth and the reduction of inflammation at a faster rate. These innovations, tried out by adopting 3D printing and self-assembly mechanisms, are the next generation way of providing targeted and effective diabetic wound treatments.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2016-2027

Base Year 2019

Forecast Period 2020-2027

Historical Period 2016-2018

Value (USD Billion)

SegmentationBy Ulcer Type

Foot Ulcer

Neuropathic Ulcer

Ischemic Ulcers

Neuro-Ischemic Ulcer

Mouth Ulcer

Others

By Treatment Type

Wound-care Dressings

Antimicrobial Dressing

Foam Dressings,

Film Dressings

Alginate Dressings

Hydrogel Dressings

Other Dressings

Wound Care Devices

Negative Pressure Wound Therapy (NPWT)

Ultrasound Therapy

Hyperbaric Oxygen Therapy (HBOT)

Others

Active Therapies

Skin Grafts & Substitutes

Growth Factors

Others

Others

By End User

Hospitals

Clinics

Ambulatory Surgical Centers

Homecare Settings

By Geography

North America (U.S. and Canada)

Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East& Africa (South Africa, GCC and Rest of Middle East & Africa)

Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Overview of Diabetic Ulcers By Key Country/Sub-region
4.2. Novel & Upcoming Innovative Treatment Options for Diabetic Ulcers
4.3. The Regulatory and Reimbursement Scenario By Country/Sub-region
4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, New Product Launches, etc.)
4.5. Impact of COVID-19 on Diabetic Ulcers Market
5. Global Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Ulcer Type
5.2.1. Foot Ulcer
5.2.1.1. Neuropathic Ulcer
5.2.1.2. Ischemic Ulcer
5.2.1.3. Neuro-ischemic Ulcer
5.2.2. Mouth Ulcer
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Treatment Type
5.3.1. Wound-care Dressings
5.3.1.1. Antimicrobial Dressing
5.3.1.2. Foam Dressings
5.3.1.3. Film Dressings
5.3.1.4. Alginate Dressings
5.3.1.5. Hydrogel Dressings
5.3.1.6. Other Dressings
5.3.2. Wound Care Devices
5.3.2.1. Negative Pressure Wound Therapy (NPWT)
5.3.2.2. Ultrasound Therapy
5.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
5.3.2.4. Others
5.3.3. Active Therapies
5.3.3.1. Skin Grafts & Substitutes
5.3.3.2. Growth Factors
5.3.3.3. Others
5.3.4. Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Hospitals
5.4.2. Clinics
5.4.3. Ambulatory Surgical Centers
5.4.4. Homecare Settings
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
6.1. Key Findings / Summary
6.2. Market Analysis – By Ulcer Type
6.2.1. Foot Ulcer
6.2.1.1. Neuropathic Ulcer
6.2.1.2. Ischemic Ulcer
6.2.1.3. Neuro-ischemic Ulcer
6.2.2. Mouth Ulcer
6.2.3. Others
6.3. Market Analysis – By Treatment Type
6.3.1. Wound-care Dressings
6.3.1.1. Antimicrobial Dressing
6.3.1.2. Foam Dressings
6.3.1.3. Film Dressings
6.3.1.4. Alginate Dressings
6.3.1.5. Hydrogel Dressings
6.3.1.6. Other Dressings
6.3.2. Wound Care Devices
6.3.2.1. Negative Pressure Wound Therapy (NPWT)
6.3.2.2. Ultrasound Therapy
6.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
6.3.2.4. Others
6.3.3. Active Therapies
6.3.3.1. Skin Grafts & Substitutes
6.3.3.2. Growth Factors
6.3.3.3. Others
6.3.4. Others
6.4. Market Analysis – By End User
6.4.1. Hospitals
6.4.2. Clinics
6.4.3. Ambulatory Surgical Centers
6.4.4. Homecare Settings
6.5. Market Analysis – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
7.1. Key Findings / Summary
7.2. Market Analysis – By Ulcer Type
7.2.1. Foot Ulcer
7.2.2. Neuropathic Ulcer
7.2.3. Ischemic Ulcer
7.2.4. Neuro-ischemic Ulcer
7.2.5. Mouth Ulcer
7.2.6. Others
7.3. Market Analysis – By Treatment Type
7.3.1. Wound-care Dressings
7.3.1.1. Antimicrobial Dressing
7.3.1.2. Foam Dressings
7.3.1.3. Film Dressings
7.3.1.4. Alginate Dressings
7.3.1.5. Hydrogel Dressings
7.3.1.6. Other Dressings
7.3.2. Wound Care Devices
7.3.2.1. Negative Pressure Wound Therapy (NPWT)
7.3.2.2. Ultrasound Therapy
7.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
7.3.2.4. Others
7.3.3. Active Therapies
7.3.3.1. Skin Grafts & Substitutes
7.3.3.2. Growth Factors
7.3.3.3. Others
7.3.4. Others
7.4. Market Analysis – By End User
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Ambulatory Surgical Centers
7.4.4. Homecare Settings
7.5. Market Analysis – By Country/Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
8.1. Key Findings / Summary
8.2. Market Analysis – By Ulcer Type
8.2.1. Foot Ulcer
8.2.1.1. Neuropathic Ulcer
8.2.1.2. Ischemic Ulcer
8.2.1.3. Neuro-ischemic Ulcer
8.2.2. Mouth Ulcer
8.2.3. Others
8.3. Market Analysis – By Treatment Type
8.3.1. Wound-care Dressings
8.3.1.1. Antimicrobial Dressing
8.3.1.2. Foam Dressings
8.3.1.3. Film Dressings
8.3.1.4. Alginate Dressings
8.3.1.5. Hydrogel Dressings
8.3.1.6. Other Dressings
8.3.2. Wound Care Devices
8.3.2.1. Negative Pressure Wound Therapy (NPWT)
8.3.2.2. Ultrasound Therapy
8.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
8.3.2.4. Others
8.3.3. Active Therapies
8.3.3.1. Skin Grafts & Substitutes
8.3.3.2. Growth Factors
8.3.3.3. Others
8.3.4. Others
8.4. Market Analysis – By End User
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Ambulatory Surgical Centers
8.4.4. Homecare Settings
8.5. Market Analysis – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
9.1. Key Findings / Summary
9.2. Market Analysis – By Ulcer Type
9.2.1. Foot Ulcer
9.2.1.1. Neuropathic Ulcer
9.2.1.2. Ischemic Ulcer
9.2.1.3. Neuro-ischemic Ulcer
9.2.2. Mouth Ulcer
9.2.3. Others
9.3. Market Analysis – By Treatment Type
9.3.1. Wound-care Dressings
9.3.1.1. Antimicrobial Dressing
9.3.1.2. Foam Dressings
9.3.1.3. Film Dressings
9.3.1.4. Alginate Dressings
9.3.1.5. Hydrogel Dressings
9.3.1.6. Other Dressings
9.3.2. Wound Care Devices
9.3.2.1. Negative Pressure Wound Therapy (NPWT)
9.3.2.2. Ultrasound Therapy
9.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
9.3.2.4. Others
9.3.3. Active Therapies
9.3.3.1. Skin Grafts & Substitutes
9.3.3.2. Growth Factors
9.3.3.3. Others
9.3.4. Others
9.4. Market Analysis – By End User
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical Centers
9.4.4. Homecare Settings
9.5. Market Analysis – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Diabetic Ulcer Treatment Market Analysis, Insights and Forecast, 2016-2027
10.1. Key Findings / Summary
10.2. Market Analysis – By Ulcer Type
10.2.1. Foot Ulcer
10.2.1.1. Neuropathic Ulcer
10.2.1.2. Ischemic Ulcer
10.2.1.3. Neuro-ischemic Ulcer
10.2.2. Mouth Ulcer
10.2.3. Others
10.3. Market Analysis – By Treatment Type
10.3.1. Wound-care Dressings
10.3.1.1. Antimicrobial Dressing
10.3.1.2. Foam Dressings
10.3.1.3. Film Dressings
10.3.1.4. Alginate Dressings
10.3.1.5. Hydrogel Dressings
10.3.1.6. Other Dressings
10.3.2. Wound Care Devices
10.3.2.1. Negative Pressure Wound Therapy (NPWT)
10.3.2.2. Ultrasound Therapy
10.3.2.3. Hyperbaric Oxygen Therapy (HBOT)
10.3.2.4. Others
10.3.3. Active Therapies
10.3.3.1. Skin Grafts & Substitutes
10.3.3.2. Growth Factors
10.3.3.3. Others
10.3.4. Others
10.4. Market Analysis – By End User
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.4.4. Homecare Settings
10.5. Market Analysis – By Country/Sub-region
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2019)
11.3. Competition Dashboard
11.4. Comparative Analysis – Major Players
11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
11.5.1. Coloplast Corp
11.5.1.1. Overview,
11.5.1.2. Products & services,
11.5.1.3. SWOT analysis,
11.5.1.4. Recent developments,
11.5.1.5. strategies,
11.5.1.6. financials (based on availability)
11.5.2. Smith & Nephew
11.5.2.1. Overview,
11.5.2.2. Products & services,
11.5.2.3. SWOT analysis,
11.5.2.4. Recent developments,
11.5.2.5. strategies,
11.5.2.6. financials (based on availability)
11.5.3. ConvaTec Group Plc
11.5.3.1. Overview,
11.5.3.2. Products & services,
11.5.3.3. SWOT analysis,
11.5.3.4. Recent developments,
11.5.3.5. strategies,
11.5.3.6. financials (based on availability)
11.5.4. Mölnlycke Health Care AB.
11.5.4.1. Overview,
11.5.4.2. Products & services,
11.5.4.3. SWOT analysis,
11.5.4.4. Recent developments,
11.5.4.5. strategies,
11.5.4.6. financials (based on availability)
11.5.5. 3M
11.5.5.1. Overview,
11.5.5.2. Products & services,
11.5.5.3. SWOT analysis,
11.5.5.4. Recent developments,
11.5.5.5. strategies,
11.5.5.6. financials (based on availability)
11.5.6. Integra LifeSciences Corporation.
11.5.6.1. Overview,
11.5.6.2. Products & services,
11.5.6.3. SWOT analysis,
11.5.6.4. Recent developments,
11.5.6.5. strategies,
11.5.6.6. financials (based on availability)
11.5.7. Cardinal Health.
11.5.7.1. Overview,
11.5.7.2. Products & services,
11.5.7.3. SWOT analysis,
11.5.7.4. Recent developments,
11.5.7.5. strategies,
11.5.7.6. financials (based on availability)
11.5.8. Tissue Regenix
11.5.8.1. Overview,
11.5.8.2. Products & services,
11.5.8.3. SWOT analysis,
11.5.8.4. Recent developments,
11.5.8.5. strategies,
11.5.8.6. financials (based on availability)
11.5.9. B. Braun Melsungen AG
11.5.9.1. Overview,
11.5.9.2. Products & services,
11.5.9.3. SWOT analysis,
11.5.9.4. Recent developments,
11.5.9.5. strategies,
11.5.9.6. financials (based on availability)
11.5.10. Other Players
11.5.10.1. Overview,
11.5.10.2. Products & services,
11.5.10.3. SWOT analysis,
11.5.10.4. Recent developments,
11.5.10.5. strategies,
11.5.10.6. financials (based on availability)
12. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings